Landfar Bio-medicine Revenue

In the year 2025, Landfar Bio-medicine had annual revenue of 415.94M CNY with 209.37% growth. Landfar Bio-medicine had revenue of 332.50M in the quarter ending December 31, 2025, with 691.09% growth.

Revenue

415.94M

Revenue Growth

+209.37%

P/S Ratio

7.53

Revenue / Employee

1.10M

Employees

378

Market Cap

3.13B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	415.94M	281.49M	209.37%
Dec 31, 2024	134.45M	-2.34M	-1.71%
Dec 31, 2023	136.79M	-63.55M	-31.72%
Dec 31, 2022	200.35M	43.73M	27.92%
Jan 1, 2022	156.62M	-18.95M	-10.79%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Yantai Zhenghai Biotechnology	347.75M
Shenzhen Bioeasy Biotechnology	271.53M
Beijing Kawin Technology Share-Holding	1.30B
Shanghai Model Organisms Center	421.02M
Guangdong VTR Bio-Tech	832.26M
Novoprotein Scientific	151.51M
Jiangsu Sihuan Bioengineering	344.38M
Shanghai Shen Lian Biomedical	288.27M

Revenue Rankings